135 related articles for article (PubMed ID: 6213873)
1. [Dental care for hemophilic patients. I. General discussion].
Ned Tijdschr Tandheelkd; 1982 Apr; 89(4):143-9. PubMed ID: 6213873
[No Abstract] [Full Text] [Related]
2. [Dental care for hemophilic patients. II. Consequences for dental practice].
Ned Tijdschr Tandheelkd; 1982 May; 89(5):200-5. PubMed ID: 6213874
[No Abstract] [Full Text] [Related]
3. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
4. Maintenance of treatment logs by haemophilia patients.
du Treil S; Rice J; Leissinger CA
Haemophilia; 2010 May; 16(3):545-7. PubMed ID: 20050930
[No Abstract] [Full Text] [Related]
5. [Dentition restoration in hemophilia under substitution of AHG concentrates].
Tetsch P; Esser E
Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700
[No Abstract] [Full Text] [Related]
6. [On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)].
Fonio A
Schweiz Med Wochenschr; 1966 Dec; 96(51):1723-6. PubMed ID: 5973382
[No Abstract] [Full Text] [Related]
7. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].
Nemes L; Ceglédi A; Szabó G; Varga M; Sas G
Orv Hetil; 1998 Mar; 139(13):749-52. PubMed ID: 9578703
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
10. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
Sharp HK; McIlveen LP; Schuman NJ
Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
[No Abstract] [Full Text] [Related]
11. [Problems in the dental treatment of a case of hemophilia A].
Sakai M; Saito T; Ikeshima K; Kamata M; Yoshikawa T; Kaneko M; Kamioka H; Masujima J; Ikeda M; Sato H
Tohoku Shika Daigaku Gakkai Shi; 1986 Mar; 13(1):37-43. PubMed ID: 2943645
[No Abstract] [Full Text] [Related]
12. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
Björkman S; Folkesson A; Berntorp E
Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
[TBL] [Abstract][Full Text] [Related]
13. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
Miranda ML; Lissen E; Vinuesa M; Jiménez JM; García de Pesquera F; Leal M
Med Clin (Barc); 1985 Apr; 84(13):516-9. PubMed ID: 3923278
[No Abstract] [Full Text] [Related]
14. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
[TBL] [Abstract][Full Text] [Related]
15. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
17. Factor products in the treatment of hemophilia.
Miller KL
J Pediatr Health Care; 2004; 18(3):156-7. PubMed ID: 15129219
[No Abstract] [Full Text] [Related]
18. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
19. Prophylaxis in children with hemophilia: is it the optimal treatment?
Lusher JM
Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
[No Abstract] [Full Text] [Related]
20. Use of activated prothrombin complex concentrate in a severely hemophilic patient with Factor VIII inhibitor.
Garehime WJ; Pecaro BC; Green D
J Oral Maxillofac Surg; 1983 Apr; 41(4):262-4. PubMed ID: 6220139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
